US Patent No. 10,124,050

IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF


Patent No. 10,124,050
Issue Date November 13, 2018
Title Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens, Kits Comprising The Same And Uses Thereof
Inventorship Wendy Jo Watson, Blue Bell, PA (US)
Luis Pascual Jodar Martin-Montalvo, Villanova, PA (US)
Raul Enrique Isturiz, Norristown, PA (US)
Ralf Rene Reinert, Bad Soden am Taunus (DE)
Assignee Pfizer Inc., New York, NY (US)

Claim of US Patent No. 10,124,050

1. A kit comprising:(a) a first immunogenic composition comprising a glycoconjugate from Streptococcus pneumoniae serotype 15B, a glycoconjugate from S. pneumoniae serotype 22F, a glycoconjugate from S. pneumoniae serotype 12F, a glycoconjugate from S. pneumoniae serotype 10A, a glycoconjugate from S. pneumoniae serotype 11A and a glycoconjugate from S. pneumoniae serotype 8; and
(b) a second immunogenic composition comprising glycoconjugates from S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, for simultaneous, concurrent, concomitant or sequential administration of the first and second immunogenic compositions.